APA (7th ed.) Citation

Curtis, S. P., Bockow, B., Fisher, C., Olaleye, J., Compton, A., Ko, A. T., & Reicin, A. S. (2005). Etoricoxib in the treatment of osteoarthritis over 52-weeks: A double-blind, active-comparator controlled trial [NCT00242489]. BMC Musculoskeletal Disorders, 6, 58. https://doi.org/10.1186/1471-2474-6-58

Chicago Style (17th ed.) Citation

Curtis, Sean P., Barry Bockow, Chester Fisher, Joseph Olaleye, Amy Compton, Amy T. Ko, and Alise S. Reicin. "Etoricoxib in the Treatment of Osteoarthritis over 52-weeks: A Double-blind, Active-comparator Controlled Trial [NCT00242489]." BMC Musculoskeletal Disorders 6 (2005): 58. https://doi.org/10.1186/1471-2474-6-58.

MLA (9th ed.) Citation

Curtis, Sean P., et al. "Etoricoxib in the Treatment of Osteoarthritis over 52-weeks: A Double-blind, Active-comparator Controlled Trial [NCT00242489]." BMC Musculoskeletal Disorders, vol. 6, 2005, p. 58, https://doi.org/10.1186/1471-2474-6-58.